Testing for Mycoplasma genitalium in pelvic inflammatory disease: A clinical audit
File version
Version of Record (VoR)
Author(s)
Thng, Caroline
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
The records of women attending Gold Coast health hospital sites were retrospectively analysed to determine if women diagnosed with pelvic inflammatory disease (PID) were being tested for Mycoplasma genitalium (MG). Only 11.4% of 299 women were tested for MG despite 74.2% being tested for Chlamydia trichomonas (CT) and Neisseria gonorrhoeae (NG). Only 9% of the women were treated with antibiotics which would treat macrolide-sensitive MG infection. Increasing education and awareness of MG and utilising reflex macrolide testing for MG will help direct effective antibiotic therapy and prevent the long-term sequalae of PID.
Journal Title
Australian and New Zealand Journal of Obstetrics and Gynaecology
Conference Title
Book Title
Edition
Volume
62
Issue
6
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2022 The Authors. Australian and New Zealand Journal of Obstetrics and Gynaecology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Obstetricians and Gynaecologists. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Item Access Status
Note
Access the data
Related item(s)
Subject
Reproductive medicine
Public health
Health services and systems
Persistent link to this record
Citation
Beesley, V; Thng, C, Testing for Mycoplasma genitalium in pelvic inflammatory disease: A clinical audit, Australian and New Zealand Journal of Obstetrics and Gynaecology, 2022, 62 (6), pp. 826-829